Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions.

The company’s CorPath® System is the first FDA-cleared medical device to bring robotic-assisted precision to radial, coronary and peripheral procedures. During the procedure, the interventional cardiologist sits at a radiation-shielded workstation to advance stents and guidewires with millimeter-by-millimeter precision.

The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries. With the CorPath System, Corindus Vascular Robotics brings robotic precision to radial and complex interventional procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement with manual procedures.

Corindus is currently the only company developing and offering robotic solutions for coronary and peripheral vascular interventions performed in cath labs.

The company sells its products through direct sales force and distributor relationships in the United States and internationally. It serves vascular, coronary, peripheral vascular, neurointerventional, and structural heart markets.

The company was founded in 2002 and is based in Waltham, Massachusetts.